These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6113285)

  • 1. Approaches to vasodilating/beta-adrenergic blocking agents: examples of the dihydrolutidine type.
    Baldwin JJ; Hirschmann R; Engelhardt EL; Ponticello GS; Sweet CS; Scriabine A
    J Med Chem; 1981 May; 24(5):628-31. PubMed ID: 6113285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
    Baldwin JJ; Engelhardt EL; Hirschmann R; Ponticello GS; Atkinson JG; Wasson BK; Sweet CS; Scriabine A
    J Med Chem; 1980 Jan; 23(1):65-70. PubMed ID: 6102151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity.
    Kreighbaum WE; Matier WL; Dennis RD; Minielli JL; Deitchman D; Perhach JL; Comer WT
    J Med Chem; 1980 Mar; 23(3):285-9. PubMed ID: 6102605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An approach to peripheral vasodilator-beta-adrenergic blocking agents.
    Baldwin JJ; Hirschmann R; Lumma PK; Lumma WC; Ponticello GS; Sweet CS; Scriabine A
    J Med Chem; 1977 Aug; 20(8):1024-9. PubMed ID: 19628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of asymmetric 4-aryl-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylates with vasodilating and antihypertensive activities.
    Ohno S; Komatsu O; Mizukoshi K; Ichihara K; Nakamura Y; Morishima T; Sumita K
    Chem Pharm Bull (Tokyo); 1986 Apr; 34(4):1589-606. PubMed ID: 3719860
    [No Abstract]   [Full Text] [Related]  

  • 6. [Synthesis of 5-(3-tert-butylamino-2-hydroxypropoxy)-8-hydroxy-3,4-dihydrocarbostyril hydrochloride and its beta-adrenergic blocking activity].
    Uchida M; Tominaga M; Oka K; Tone H; Uno T
    Yakugaku Zasshi; 1976 May; 96(5):571-7. PubMed ID: 9501
    [No Abstract]   [Full Text] [Related]  

  • 7. beta-Adrenergic blocking agents with acute antihypertensive activity.
    Baldwin JJ; Engelhardt EL; Hirschmann R; Lundell GF; Ponticello GS; Ludden CT; Sweet CS; Scriabine A; Share NN; Hall R
    J Med Chem; 1979 Jun; 22(6):687-94. PubMed ID: 37337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-short-acting beta-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function.
    Erhardt PW; Woo CM; Anderson WG; Gorczynski RJ
    J Med Chem; 1982 Dec; 25(12):1408-12. PubMed ID: 6130154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-short-acting beta-adrenergic receptor blocking agents. 1. (Aryloxy)propanolamines containing esters in the nitrogen substituent.
    Erhardt PW; Woo CM; Gorczynski RJ; Anderson WG
    J Med Chem; 1982 Dec; 25(12):1402-7. PubMed ID: 6130153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of certain 3-[4-[2-hydroxy-3-(isopropylamino) propoxy]phenyl]propionate as beta-adrenergic blocking agents.
    Ahmed AN
    J Pharm Belg; 1987; 42(6):389-94. PubMed ID: 2895806
    [No Abstract]   [Full Text] [Related]  

  • 11. 2-(Isoxazolylethenyl)phenoxypropanolamines: a new class of beta-receptor antagonists with antihypertensive activity.
    Franke A; Frickel FF; Gries J; Lenke D; Schlecker R; Thieme PD
    J Med Chem; 1981 Dec; 24(12):1460-4. PubMed ID: 6118439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-adrenergic blocking agents. 24. Heterocyclic substituted 1-(aryloxy)-3-[[(amido)alkyl]amino]propan-2-ols.
    Large MS; Smith LH
    J Med Chem; 1982 Dec; 25(12):1417-22. PubMed ID: 6130155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and beta-adrenergic blocking activity of oxipropanolamines of 3,4-dihydro-3-oxo-2H(1,4)benzothiazine.
    Cecchetti V; Fravolini A; Fringuelli R; Schiaffella F; Mascellani G; Pagella PG; Rugarli PL
    Farmaco Sci; 1987 Jan; 42(1):61-75. PubMed ID: 2898382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of (S)-(trifloxymethyl)oxirane in the synthesis of a chiral beta-adrenoceptor antagonist, (R)- and (S)-9-[[3-(tert-butylamino)-2-hydroxypropyl]oximino]fluorene.
    Baldwin JJ; McClure DE; Gross DM; Williams M
    J Med Chem; 1982 Aug; 25(8):931-6. PubMed ID: 6126588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on agents with vasodilator and beta-blocking activities. II.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Tanimoto Y; Yamaguchi T; Saitoh M; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):247-55. PubMed ID: 7728931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses of the optical isomers of befunolol.HCl and their beta-adrenergic blocking activities.
    Nakano J; Mimura M; Hayashida M; Fujii M; Kimura K; Nakanishi T
    Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1399-403. PubMed ID: 2901296
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and beta-adrenergic antagonist activity of novel (3-oxazolinyl-1,4-dihydropyridyl) propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1992 Jul; 8(4):265-72. PubMed ID: 1359908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and beta-adrenergic blocking action of a new thiazolylthiopropanolamine derivative.
    Hara Y; Sato E; Miyagishi A; Aisaka A; Hibino T
    J Pharm Sci; 1978 Sep; 67(9):1334-5. PubMed ID: 29117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavones. 1. Synthesis and antihypertensive activity of (3-phenylflavonoxy)propanolamines without beta-adrenoceptor antagonism.
    Wu ES; Cole TE; Davidson TA; Blosser JC; Borrelli AR; Kinsolving CR; Milgate TE; Parker RB
    J Med Chem; 1987 May; 30(5):788-92. PubMed ID: 2883317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis of aryloxypropanolamines with chromone or coumarin structures. Study of beta-blocking activity].
    Gesquière JC; Dhaisne JM; Marcinal-Lefebvre A; Bar D; Vincent A; Dupuis B
    Ann Pharm Fr; 1982 Sep; 40(3):251-7. PubMed ID: 6129826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.